Traveler's diarrhea

Area of Science:

• Infectious Diseases
• Travel Medicine
• Microbiology

Background:

• Millions of travelers experience acute diarrhea annually, primarily in developing countries.
• Contaminated food and water are the main sources of infection, with bacteria like E. coli, Salmonella, and Shigella being common culprits.
• While parasites and viruses can cause diarrhea, bacterial infections are more prevalent.

Purpose of the Study:

• To review the causes, risk factors, and treatment of traveler's diarrhea.
• To discuss the efficacy of various treatment options, including antibiotics and loperamide.
• To provide guidance on selecting appropriate antimicrobial agents based on geographic location and causative pathogens.

Main Methods:

• Review of existing literature on traveler's diarrhea.
• Analysis of common bacterial, parasitic, and viral etiologies.
• Evaluation of treatment guidelines and drug efficacy.

Main Results:

• Travel destination is the most significant risk factor for traveler's diarrhea.
• Pretravel counseling and dietary precautions have unproven efficacy in prevention.
• Empiric antibiotic treatment, often with loperamide, is effective in limiting symptoms to one day.
• Rifaximin is suitable for regions with noninvasive E. coli; fluoroquinolones are preferred for invasive pathogens like Campylobacter and Shigella.
• Azithromycin is recommended for quinolone-resistant Campylobacter and for pediatric or pregnant patients.

Conclusions:

• Traveler's diarrhea is a common ailment with identifiable causes and effective treatment options.
• Antibiotic selection for traveler's diarrhea should be guided by regional epidemiology of pathogens.
• Further research may be needed to establish the efficacy of preventive measures.